Early Contact with Palliative Care Services: A Randomized Trial in Patients with Newly Detected Incurable Metastatic Cancer

Background: It is not known when in the course of incurable cancer referral to a specialist palliative care service should optimally be made. Methods: We randomly assigned patients with newly detected incurable metastatic cancer with an estimated survival of less than 12 months to receive either (1) standard oncologic care plus contact from a palliative care nurse who served as a link to palliative care services in the hospital and community (PC) or (2) standard oncologic care alone. Quality of life (QoL) measures were assessed at baseline and monthly thereafter. The primary endpoint was quality of life over time measured by the McGill QOL total score. Findings: 120 patients were randomized, 60 to each group. Forty four patients had gastrointestinal cancer, 23 lung cancer, 19 gynaecological cancer and 17 breast cancer. The mean time since initial cancer diagnosis was 34 months in the standard care group and 29 months in the early palliative care contact group. There was no evidence that early PC nurse contact reduced symptoms or improved quality of life. If anything, there was a trend towards the opposite. There were non-significant trends for the place of death of early contact PC patients to be other than in an acute hospital, and for greater PC input during their final acute hospital admission. Early contact with palliative care was not found to influence the number of lines of chemotherapy received. Interpretation: The study did not demonstrate a QoL benefit for early contact with a PC nurse.

[1]  J. Temel,et al.  Components of early outpatient palliative care consultation in patients with metastatic nonsmall cell lung cancer. , 2011, Journal of palliative medicine.

[2]  H. Putter,et al.  Denial and social and emotional outcomes in lung cancer patients: the protective effect of denial. , 2011, Lung cancer.

[3]  Alona Muzikansky,et al.  Early palliative care for patients with metastatic non-small-cell lung cancer. , 2010, The New England journal of medicine.

[4]  Mark T Hegel,et al.  Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the Project ENABLE II randomized controlled trial. , 2009, JAMA.

[5]  A. Girgis,et al.  Brief assessment of adult cancer patients' perceived needs: development and validation of the 34-item Supportive Care Needs Survey (SCNS-SF34). , 2009, Journal of evaluation in clinical practice.

[6]  P. Maciejewski,et al.  Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. , 2008, JAMA.

[7]  George F Borm,et al.  A simple sample size formula for analysis of covariance in randomized clinical trials. , 2007, Journal of clinical epidemiology.

[8]  G. Dranitsaris,et al.  Chemotherapy-induced nausea and vomiting in breast cancer patients: a prospective observational study. , 2007, The journal of supportive oncology.

[9]  G. Dranitsaris,et al.  Prevention and management of chemotherapy-induced diarrhea in patients with colorectal cancer: a consensus statement by the Canadian Working Group on Chemotherapy-Induced Diarrhea , 2007, Current oncology.

[10]  M. Stockler,et al.  Disarming the guarded prognosis: predicting survival in newly referred patients with incurable cancer , 2005, British Journal of Cancer.

[11]  I. Finlay,et al.  The feasibility, reliability and validity of the McGill Quality of Life Questionnaire-Cardiff Short Form (MQOL-CSF) in palliative care population , 2005, Quality of Life Research.

[12]  E. Bruera,et al.  Validity of the McGill Quality of Life Questionnaire in the palliative care setting: a multi-centre Canadian study demonstrating the importance of the existential domain , 1997, Palliative medicine.

[13]  William A. Knaus,et al.  A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). The SUPPORT Principal Investigators. , 1995, JAMA.

[14]  B. Mount,et al.  The McGill Quality of Life Questionnaire: a measure of quality of life appropriate for people with advanced disease. A preliminary study of validity and acceptability , 1995, Palliative medicine.

[15]  J. de Haes,et al.  Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. , 1990, British Journal of Cancer.

[16]  I. Higginson,et al.  A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. , 2006, Journal of pain and symptom management.

[17]  F. Oort,et al.  The content and amount of information given by medical oncologists when telling patients with advanced cancer what their treatment options are. palliative chemotherapy and watchful-waiting. , 2004, European journal of cancer.

[18]  Steven Piantadosi,et al.  The prevalence of psychological distress by cancer site , 2001, Psycho-oncology.

[19]  R. Sanson-Fisher,et al.  The unmet supportive care needs of patients with cancer , 2000, Cancer.

[20]  R. Sanson-Fisher,et al.  Evaluation of an instrument to assess the needs of patients with cancer , 2000, Cancer.

[21]  R. Sanderman Measuring the quality of life of cancer patients with the Rotterdam Symptom Checklist (RSCL): a manual , 1996 .